Guggenheim on Forte Biosciences Inc. (FBRX): readout has 'highly favorable' risk/reward, set for +200% move
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja reiterated a Buy rating and $75.00 price target on Forte Biosciences Inc. (NASDAQ: FBRX)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
